340
Views
0
CrossRef citations to date
0
Altmetric
Original

Postgraduate Courses

Pages 1-41 | Published online: 08 Apr 2010

References

  • Kehlet H, Dahl JB. Anaesthesia, surgery, and challenges in postoperative recovery. Lancet 2003; 362: 1921–28
  • White PF, Kehlet H, Neal JM, Schricker T, Carr DB, Carli F. The role of the anesthesiologist in fast-track surgery: from multimodal analgesia to perioperative medical care. Anesth Analg 2007; 104: 1380–96
  • Low DE. Evolution in perioperative management of patients undergoing oesophagectomy. Br J Surg 2007; 94: 655–656
  • Kehlet H. Fast-track colorectal surgery. Lancet 2008; 371: 791–93
  • Kehlet H, Wilmore DW. Evidence-based surgical care and the evolution of fast-track surgery. Ann Surg 2008; 248: 189–98
  • Lassen K, Kjaeve J, Fetveit T, et al. Allowing normal food at will after major upper gastrointestinal surgery does not increase morbidity: a randomized multicenter trial. Ann Surg 2008; 247: 721–729
  • Yang Z, Zheng Q, Wang Z. Meta-analysis of the need for nasogastric or nasojejunal decompression after gastrectomy for gastric cancer. Br J Surg 2008; 95: 809–816
  • Delaney CP. Outcome of discharge within 24 to 72 hours after laparoscopic colorectal surgery. Dis Colon Rectum 2008; 51: 181–185
  • Wald HL, Ma A, Bratzler DW, Kramer AM. Indwelling urinary catheter use in the postoperative period: analysis of the national surgical infection prevention project data. Arch Surg 2008; 143: 551–557
  • Kehlet H. Postoperative ileus – an update on preventive techniques. Nat Clin Pract Gastroenterol Hepatol 2008; 5: 552–558
  • Muller S, Zalunardo MP, Hubner M, et al. A fast-track program reduces complications and length of hospital stay after open colonic surgery. Gastroenterology 2009; 136: 842–847
  • Slim K, Vicaut E, Launay-Savary MV, et al. Updated systematic review and meta-analysis of randomized clinical trials on the role of mechanical bowel preparation before colorectal surgery. Ann Surg 2009; 249: 203–209
  • Angulo, P. Nonalcoholic fatty liver disease. N Engl J Med 2002, Apr 18;346(16):1221–1231.
  • Marchesini, G, Bugianesi, E, Forlani, G, Cerrelli, F, Lenzi, M, Manini, R, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003, Apr;37(4):917–923.
  • Bjornsson, E, Angulo, P. Non-alcoholic fatty liver disease. Scand J Gastroenterol 2007, Sep;42(9):1023–1030.
  • Adams, LA, Lymp, JF, St, SJ, Sanderson, SO, Lindor, KD, Feldstein, A, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005, Jul;129(1):113–121.
  • Ekstedt, M, Franzen, LE, Mathiesen, UL, Thorelius, L, Holmqvist, M, Bodemar, G, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006, Oct;44(4):865–873.
  • Saadeh, S, Younossi, ZM, Remer, EM, Gramlich, T, Ong, JP, Hurley, M, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002, Sep;123(3):745–750.
  • Becker, U, Deis, A, Sorensen, TI, Gronbaek, M, Borch-Johnsen, K, Muller, CF, et al. Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology 1996, May;23(5):1025–1029.
  • Bell, H, Tallaksen, CM, Try, K, Haug, E. Carbohydrate-deficient transferrin and other markers of high alcohol consumption: a study of 502 patients admitted consecutively to a medical department. Alcohol Clin Exp Res 1994, Oct;18(5):1103–1108.
  • Haukeland, JW, Konopski, Z, Linnestad, P, Azimy, S, Løberg, E.M., Haaland, T, et al. Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease. Scand J Gastroenterol 2005;40(12):1469–1477.
  • Dixon, JB, Bhathal, PS, O'Brien, PE, Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001, Jul;121(1):91–100.
  • Harrison, SA, Day, CP. Benefits of lifestyle modification in NAFLD. Gut 2007, Dec;56(12):1760–1769.
  • Ueno, T, Sugawara, H, Sujaku, K, Hashimoto, O, Tsuji, R, Tamaki, S, et al. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J Hepatol 1997, Jul 1;27(1):103–107.
  • Belfort, R, Harrison, SA, Brown, K, Darland, C, Finch, J, Hardies, J, et al. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N Engl J Med 2006, Nov 30;355(22):2297–2307.
  • Aithal, GP, Thomas, JA, Kaye, PV, Lawson, A, Ryder, SD, Spendlove, I, et al. Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis. Gastroenterology 2008, Oct;135(4):1176–1184.
  • Ratziu, V, Giral, P, Jacqueminet, S, Charlotte, F, Hartemann-Heurtier, A, Serfaty, L, et al. Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial. Gastroenterology 2008, Jul;135(1):100–110.
  • Bugianesi, E, Gentilcore, E, Manini, R, Natale, S, Vanni, E, Villanova, N, et al. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. Am J Gastroenterol 2005, May;100(5):1082–1090.
  • Haukeland, JW, Konopski, Z, Eggesbø, H, von Volkmann, H, Raschpichler, G, Bjøro, K, et al. Metformin in patients with nonalcoholic fatty liver disease: A randomized controlled trial. Scand J Gastroenterol 2009, (in press).
  • Targher, G, Arcaro, G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis 2007, Apr;191(2):235–240.
  • Schindhelm, RK, Dekker, JM, Nijpels, G, Bouter, LM, Stehouwer, CD, Heine, RJ, et al. Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study. Atherosclerosis 2007, Apr;191(2):391–396.
  • Kamarchuk G.V., . TCNQ derivatives-based sensors for breath gas analysis. Breath Analysis for Medical Diagnosis and Therapeutic Monitoring, A. Amann, D. Smith, et al. World Scientific, Singapore 2005; 85–99
  • Bernklev T, et al. Quality of Life in Patients with Inflammatory Bowel Disease. Translation, Data Quality, Scaling Assumptions, Validity, Reliability and Sensitivity to Change of the Norwegian Version of IBDQ. Scandinavian Journal of Gastroenterology 2002; 10: 1156–1173
  • Drossman DA., et al. The Rating Form of IBD Patient Concerns: A New Measure of Health Status. Psychosomatic Medicine 1991; 53: 701–712
  • Dubinsky M. Sexual Dusfunction in Inflammatory Bowel Disease. American Journal of Gastroenterology. 2007; 102: 65–67
  • Sainsbury A., et al. Review article: psychosocial factors in the quality of life of patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2005; 21: 499–508
  • Timmer A., et al. Determinants of Male Sexual function in inflammatory Bowel Disease: A Survey-based Cross-sectional Analysis in 280 Men. Inflammatory Bowel Disease 2007; 13(10)1236–1243
  • Trachter AB., et al. Inflammatory Bowel Disease in Women. Impact on Relationship and Sexual Health. Clinical review] Inflammatory Bowel Disease 2002; 8(6)413–421

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.